Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

Investing Articles

Set to go up 57%? Here are the latest share price forecasts for AstraZeneca

| John Fieldsend

The share price forecasts for Astrazeneca are looking very bullish indeed. Here's a round up of what analysts are expecting…

Read more »

ISA Individual Savings Account
Investing Articles

I asked ChatGPT for 3 FTSE 100 picks for a Stocks and Shares ISA. Here’s what it said

| Alan Oscroft

Thinking of starting a new Stocks and Shares ISA? It's worth seeking a range of opinions, but be sure to…

Read more »

Mother and Daughter Blowing Bubbles
Investing Articles

At 217%, the ‘Warren Buffett indicator’ is higher than during the dotcom bubble! Is a crash coming?

| John Fieldsend

The Warren Buffett indicator has risen to fresh record highs. Is this a sign that a crash might be heading…

Read more »

US Tariffs street sign
Investing Articles

Is a 15% stock market correction coming? If so, I’m ready

| Mark Hartley

With experts voicing concerns, our writer outlines his defensive plan in the event a forecast stock market correction becomes reality.

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

The FTSE 100’s largest company could surpass a £200bn market valuation this year

| Dr. James Fox

AstraZeneca is the largest company on the FTSE 100, and it could soon have a more-than-£200bn valuation as the market’s…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Just over £119 now, AstraZeneca’s share price looks cheap to me anywhere under £220.91

| Simon Watkins

AstraZeneca’s share price has fallen since its September one-year high, which indicates that it could be a bargain. I ran…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

After this weekend’s news, is it time to look again at the AstraZeneca share price?

| James Beard

Over the past year, the AstraZeneca share price has fallen 11%. But could news of a potentially game-changing new drug…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

1 no-brainer UK share to consider buying with £3,000?

| Zaven Boyrazian, CFA

These are three of the most popular UK shares being bought by British investors, but are they actually good investments…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

With a rotation pending, are these the best stocks to buy in August?

| Dr. James Fox

Dr James Fox takes a closer look at what could be some of the best stocks to buy in August…

Read more »

A black male doctor chats to a senior patient on the hospital ward ,with a young female nurse wearing a hijab attending to a dressing
Investing Articles

Can this latest news kickstart AstraZeneca’s share price momentum?

| Alan Oscroft

The AstraZeneca share price has been treading water for the past few years, but first-half results add strength to rising…

Read more »

Investing Articles

2 top FTSE 100 stocks to consider buying in August

| Ben McPoland

This pair of high-quality FTSE 100 stocks look decent value to our writer, despite the blue-chip index's recent jump higher.

Read more »

Two business people sitting at cafe working on new project using laptop. Young businesswoman taking notes and businessman working on laptop computer.
Investing Articles

Here’s where the AstraZeneca share price could end the year

| Dr. James Fox

Pharma hasn’t been in vogue this year. However, Dr James Fox believes a rotation out of technologies stocks could benefit…

Read more »